Home LiteratureArticle Details
PMID: 9884387 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Age-dependent impairment of angiogenesis.

Circulation ·Vol. 99 ·No. 1 ·1999-00-00 ·Pages 111-20

Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner JM

Abstract

The effect of aging on angiogenesis in ischemic vascular disease has not been studied. Accordingly, we investigated the hypothesis that angiogenesis is impaired as a function of age. Forty days after the resection of 1 femoral artery, collateral vessel development was significantly impaired in old (aged 4 to 5 years; n=7) versus young (aged 6 to 8 months; n=6) New Zealand White (NZW) rabbits on the basis of reduced hindlimb perfusion (ischemic: normal blood pressure ratio=0.58+/-0.05 versus 0.77+/-0.06; P<0.005), reduced number of angiographically visible vessels (angiographic score=0.48+/-0.05 versus 0.70+/-0.05; P<0.01), and lower capillary density in the ischemic limb (130.3+/-5.8/mm2 versus 171.4+/-9.5/mm2; P<0.001). Angiogenesis was also impaired in old (aged 2 years) versus young (aged 12 weeks) mice as shown by reduced hindlimb perfusion (measured by laser Doppler imaging) and lower capillary density (353.0+/-14.3/mm2 versus 713.3+/-63.4/mm2; P<0.01). Impaired angiogenesis in old animals was the result of impaired endothelial function (lower basal NO release and decreased vasodilation in response to acetylcholine) and a lower expression of vascular endothelial growth factor (VEGF) in ischemic tissues (by Northern blot, Western blot, and immunohistochemistry). When recombinant VEGF protein was administered to young and old rabbits, both groups exhibited a significant and similar increase in blood pressure ratio, angiographic score, and capillary density. Angiogenesis responsible for collateral development in limb ischemia is impaired with aging; responsible mechanisms include age-related endothelial dysfunction and reduced VEGF expression. Advanced age, however, does not preclude augmentation of collateral vessel development in response to exogenous angiogenic cytokines.

MeSH Terms
Aging/physiology Animals Endothelial Growth Factors/genetics,therapeutic use Follow-Up Studies Hindlimb/blood supply Ischemia/drug therapy,physiopathology Lymphocyte Count Lymphokines/genetics,therapeutic use Male Neovascularization, Physiologic/drug effects Nitric Oxide/biosynthesis Promoter Regions, Genetic RNA, Messenger/biosynthesis Rabbits Recombinant Proteins/therapeutic use T-Lymphocytes/pathology Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Vasomotor System/drug effects,physiology
Chemicals
Endothelial Growth Factors Lymphokines RNA, Messenger Recombinant Proteins Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Nitric Oxide
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Rivard A
Departments of Medicine (Cardiology) and Biomedical Research, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA.
Fabre J E
Silver M
Chen D
Murohara T
Kearney M
Magner M
Asahara T
Isner J M
Article Info
Journal
Circulation
Abbr.
Circulation
ISSN
0009-7322
Published
1999-00-00
Pages
111-20
Language
English
Region
United States
NLM ID
0147763
Subset
IM
Grants
NHLBI NIH HHS · HL-02824 · United States
NHLBI NIH HHS · HL-53354 · United States
NHLBI NIH HHS · HL-57516 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]